a dentist thing? honestly i don't know much about it, just threw it on as a quick trade and probably would have sold at up 7% but I was in the middle of teaching when it rose and so just seeing it now.
I'd take the money and run. Looks like a straight up earnings story- One trick I do is look for analyst last mentions, if you have a few holds out there that are old- then you can assume upgrades tomorrow & you sell tomorrow. If there is recent upgrades pointing to this QTR run. Biolase sees Q4 revenue $8.2M-$8.5M, consensus $7.43M
Janes---!!! This JUST dropped Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue ยป Maxim not the best house though.. better mag.
i'm so wiped from class i'm trying to decipher your advice. re: you're saying you don't see upgrades tomorrow so best to close now vs tomorrow? i won't hold you to the advice working out...just appreciative that you're offering it.
It's not like it was a bad qtr! That's decent dough. Citron still short GameStop shares, Andrew Left tells Reuters 14:06 GME Andrew Left told Reuters that his firm Citron Research is still short shares of GameStop. Left shorted GameStop when it traded around $40 per share, and forecasted publicly that it would fall to $20, Svea Herbst-Bayliss of Reuters reports. "If I had never been involved in GameStop and came to this right now, would I still be short this stock? 100 percent. This is an old school, failing mall-based video retailer and investors can't change the perception of that," Left told Reuters. Shares of GameStop are up 47%, or $36.01, to $112.80 in afternoon trading. Left last week announced that he would stop publicly commenting on the company given threats to his family
Thanks stoney. this is my real weakness as a trader and i appreciate the coaching. i'm holding and it will be a learning experience regardless of outcome.